Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,659,565
+$311,562 QoQ
Shares Held
6,595
+6.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#2,105
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. ABBV ranks #6 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,659,565 | 6,595 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,348,003 | 6,198 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,459,137 | 6,386 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,408,457 | 6,083 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,147,502 | 6,182 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,308,661 | 6,246 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,004,538 | 5,653 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,277,103 | 6,467 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $817,464 | 4,766 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $823,820 | 4,524 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $546,114 | 3,524 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $513,511 | 3,445 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,219,980 | 9,055 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,516,883 | 9,518 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,787,729 | 11,062 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,652,392 | 19,763 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $2,634,505 | 17,201 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,088,681 | 19,053 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,831,955 | 28,301 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $3,912,660 | 36,272 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,535,111 | 40,262 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $4,456,607 | 41,181 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,378,470 | 40,863 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,496,417 | 39,918 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,905,109 | 39,775 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $3,188,170 | 41,845 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||